Ticagrelor – toward more efficient platelet inhibition and beyond

Novel antiplatelet drugs, including ticagrelor, are being successively introduced into the therapy of atherothrombotic conditions due to their superiority over a standard combination of clopidogrel with acetylsalicylic acid in patients with acute coronary syndromes (ACS). A P2Y12 receptor antagonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubisa, Michał J, Jezewski, Mateusz P, Gasecka, Aleksandra, Siller-Matula, Jolanta M, Postuła, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775739/
https://www.ncbi.nlm.nih.gov/pubmed/29398917
http://dx.doi.org/10.2147/TCRM.S152369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775739/
https://www.ncbi.nlm.nih.gov/pubmed/29398917
http://dx.doi.org/10.2147/TCRM.S152369

Ejemplares similares